Valuation BioSenic SA

Stocks

Market Closed - Euronext Bruxelles 20:55:00 29/10/2026 +04			5-day change	1st Jan Change
0.002000 ^EUR	0.00%		0.00%	-13.04%

09-24	BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
28/10/25	BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024
Market Cap ¹	2.998	9.987	1.879
Change	-	233.11%	-81.19%
Enterprise Value (EV) ¹	24.94	38.03	29.21
Change	-	52.47%	-23.17%
P/E	-5.65x	-0.29x	-0.28x
PBR	6.54x	-0.44x	-0.07x
PEG	-	-0x	0x
Capitalization / Revenue	10.1x	29.7x	18.4x
EV / Revenue	84.3x	113x	286x
EV / EBITDA	-10.8x	-5.43x	-5.94x
EV / EBIT	-10.8x	-5.4x	-5.61x
EV / FCF	-13.3x	-17x	-7.16x
FCF Yield	-7.49%	-5.89%	-14%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.017	-0.2102	-0.0206
Distribution rate	-	-	-
Net sales ¹	0.296	0.336	0.102
EBITDA ¹	-2.299	-6.998	-4.915
EBIT ¹	-2.318	-7.039	-5.206
Net income ¹	-2.041	-28.78	-4.768
Net Debt ¹	21.94	28.04	27.34
Reference price ²	0.096000	0.061200	0.005800
Nbr of stocks (in thousands)	31,229	163,181	323,932
Announcement Date	12/07/24	12/07/24	03/10/25

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOSENIC SA	-	-	-	-	1.46M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	403.72B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%